V
Power Law company profile
Vir Biotechnology
Biotech & Life Sciences · San Francisco, United States · Founded 2016 · IPO 2019 Unicorn
Valuation
$1.26B
Market cap · Apr/2026
Revenue
$69M
Latest reported FY
Global footprint
Where Vir Biotechnology has talent and traffic
AI talent share
0.8%
of workforce is AI talent
(4 of 479 staff)
(4 of 479 staff)
Core AI20.42%
Other AI20.42%
Non-AI workforce47599.16%
Web traffic by country
38K
monthly visits
across markets
across markets
🇺🇸 United States29.5%
🇨🇦 Canada28.2%
🇬🇧 United Kingdom8.7%
🇮🇳 India6.6%
🇵🇭 Philippines5.3%
Patent intelligence
$126M patent portfolio · 118 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$126M
10.0% of market cap · 2.9× the top peer ADMA Biologics ($44M)
118 active patent families
Where Vir Biotechnology innovates
VirologyMolecular biologyAntigen Binding FragmentBioinformaticsAntigen
Below peer median on Strategic, Market
Quality vs same-sector peers
Vir Biotechnology on the five Patsnap quality dimensions
Vir Biotechnology in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Vir Biotechnology concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Vir Biotechnology and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Vir Biotechnology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.